syndax.com (SNDX) - מזומנים למניה

Syndax Corp - לוגו גרפי של המנפיק SNDX

The cash position per share chart for Syndax Pharmaceuticals (SNDX) on GURU.Markets demonstrates liquidity dynamics, where 4.74 characterizes this valuation parameter. Growth is supported by epigenetic developments that restore tumor sensitivity to therapy. However, volatility is driven by dependence on FDA verdicts and the high cost of research, while revenue stability is limited by strict distribution protocols for leukemia treatment drugs.

Syndax Pharmaceuticals Inc - מזומנים למניה אחת SNDX (תקופה 04.07.2022 - 20.11.2026)

פילוחי מדדים מקיפים ואנליטיקה עבור Syndax Pharmaceuticals, Inc. (SNDX)

- מחיר נוכחי ושווי מניות חזוי:
- מדדי זמינות כספים ותזרימי מזומנים:
ניתוח מסכם של החברה:SNDX, Syndax Corp
מוצרים מיוצרים של syndax.com

To identify fundamentally resilient assets, investors evaluate liquidity per share to determine a business's margin of safety against its debt obligations. The current value of 4.74 reflects the ability of Syndax Pharmaceuticals (SNDX) to fund revumenib clinical trials and expansion within the hemato-oncology segment without external borrowing, a fact confirmed by the trend in cash per share.